Doctor Cosme Garcia-Garcia
Germans Trias i Pujol University Hospital, Barcelona (Spain)
Membership:
FESC Member
Biography
Dr. Cosme Garcia, MD, PhD, FESC, Head of the Cardiology Department at the Heart Institute ol Germans Trias i Pujol University Hospital (2025), before that, Chief of Acute Cardiac Care Unit (2015). Associate Professor at the Autonomous University of Barcelona (2021--). Degree in Medicine and Surgery in 1998 at the University of Barcelona, specialization in Cardiology and Doctorate in Medicine, graduating cum laude (2013). He holds European certification from the ACCA. He enriched his expertise with Diploma in Health Sciences Statistics (2006), and Master’s Degrees in Acute Cardiac Care (2014) and Master in Direction and Management of Clinical Units (2017). He has directed 8 doctoral theses, authored more than 90 peer-reviewed publications, more than 280 scientific communications, and leadership in multiple competitive research projects, including grants from the Carlos III Health Institute. Cardiogenic shock, myocardial infartion and cardiovascular epidemiology are his research areas.
Contributor content
Presentation
Oncostatin M is associated with a higher risk profile and predicts a worse outcome in patients with STEMI
Presentation
Primary ventricular fibrillation in the STEMI code era: trends and acute-phase mortality over the last 15 years
Presentation
Prognostic implications of fasting hyperglycaemia in patients with cardiogenic shock. A mediterranean cohort: results from the Shock-CAT study.
Presentation
Primary ventricular fibrillation epidemic in the STEMI Code era. Trends and acute-phase mortality over the last 15 years
Presentation
Concomitant cardiac arrest on cardiogenic shock patients. Differences in clinical profile and outcomes with non-cardiac arrest patients. The Shock CAT Study
Presentation
Gender-based differences in clinical profile, management and mortality in cardiogenic shock. Prognostic accuracy of CardShock vs IABP Score, the Shock-CAT study
Presentation
In-hospital mortality and 6-months prognosis on cardiogenic shock depending on the aetiology in a Mediterranean cohort. The Shock-CAT Study
Presentation
Mortality risk in cardiogenic shock: Head to head comparison CardShock vs IABP score depending on aetiology, the Shock CAT study
Presentation
Mortality risk in cardiogenic shock: head to head comparision CardShock vs IABP Score in a Mediterranean cohort, the Shock CAT Study
Presentation
